Terumo Cardiovascular Systems Corporation
Form 483 issued July 11, 2015 · Ann Arbor, Michigan
- Inspection
- May 10 – May 18, 2004
- Observations
- 19
- Pages
- 8
- FEI number
- 1828100
In short: On July 11, 2015, FDA issued a Form 483 with 19 observations to Terumo Cardiovascular Systems Corporation in Ann Arbor, Michigan (FEI 1828100) after an inspection that ran May 10 – May 18, 2004. Most observations concern cAPA and management controls; the most-cited regulation is 21 CFR 820.30 (design controls).
At a glance
CAPA and management controls account for 10 of 13 observations.
Most cited: 21 CFR 820.30 (3×) · 820.100 (3×)
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
Management with executive responsibility has not ensured that an adequate and effective quality system has been…
- 02
Quality audits did not verify that the quality system is .effective in fulfilling…
- 03
Quality audits were not conducted at sufficient regular intervals, as prescribed by internal procedures to verifY…
- 04
Observation 4: scanned text, readable in the full document.
This inspection in context
Questions about this 483
What did FDA find at Terumo Cardiovascular Systems Corporation?
FDA listed 19 observations on this Form 483, mostly about cAPA, management controls and design controls. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.
When was Terumo Cardiovascular Systems Corporation inspected by FDA?
The inspection ran May 10 – May 18, 2004, and the Form 483 is dated July 11, 2015.
How do I get the full Form 483 for Terumo Cardiovascular Systems Corporation?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.